We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
101
Amgen
AMGN
$206B
$10.6M 0.03%
33,933
+1,116
+3% +$330K
PLD icon
102
Prologis
PLD
$128B
$10.3M 0.03%
92,272
+4,326
+5% +$500K
TTE icon
103
TotalEnergies
TTE
$201B
$10.1M 0.03%
156,551
-79,395
-34% -$4.79M
OKE icon
104
Oneok
OKE
$61.1B
$9.23M 0.02%
93,075
+2,967
+3% +$295K
CPRT icon
105
Copart
CPRT
$29.4B
$8.97M 0.02%
158,575
DLR icon
106
Digital Realty Trust
DLR
$66.5B
$8.95M 0.02%
62,447
SBUX icon
107
Starbucks
SBUX
$113B
$8.93M 0.02%
91,056
+5,991
+7% +$619K
BSM icon
108
Black Stone Minerals
BSM
$3.17B
$7.49M 0.02%
490,740
AMT icon
109
American Tower
AMT
$82.4B
$7.41M 0.02%
34,031
-2,870
-8% -$563K
BUD icon
110
AB InBev
BUD
$157B
$7.21M 0.02%
117,056
-450
-0.4% -$24.6K
OVV icon
111
Ovintiv
OVV
$18.1B
$7.1M 0.02%
165,824
AON icon
112
Aon
AON
$66.1B
$7.07M 0.02%
17,716
+1,274
+8% +$488K
ROK icon
113
Rockwell Automation
ROK
$46.5B
$6.93M 0.02%
26,838
-30
-0.1% -$8.35K
LMT icon
114
Lockheed Martin
LMT
$122B
$6.9M 0.02%
15,441
-1,201
-7% -$553K
PFE icon
115
Pfizer
PFE
$158B
$6.64M 0.02%
262,092
-6,983
-3% -$183K
DUK icon
116
Duke Energy
DUK
$92.8B
$6.41M 0.02%
52,560
-986
-2% -$112K
K
117
DELISTED
Kellanova
K
$6.39M 0.02%
77,480
-150
-0.2% -$12.3K
HDB icon
118
HDFC Bank
HDB
$118B
$6.24M 0.02%
187,870
+13,670
+8% +$417K
SCI icon
119
Service Corp International
SCI
$11.1B
$5.96M 0.01%
74,325
QQQ icon
120
Invesco QQQ Trust
QQQ
$477B
$5.64M 0.01%
12,026
+2,627
+28% +$1.33M
CHKP icon
121
Check Point Software Technologies
CHKP
$14.1B
$5.55M 0.01%
24,329
+1,534
+7% +$325K
CARR icon
122
Carrier Global
CARR
$47.2B
$5.2M 0.01%
82,088
-428
-0.5% -$28.4K
VRTX icon
123
Vertex Pharmaceuticals
VRTX
$132B
$5.04M 0.01%
10,392
IBM icon
124
IBM
IBM
$235B
$4.81M 0.01%
19,342
-151
-0.8% -$36.9K
ITW icon
125
Illinois Tool Works
ITW
$76.6B
$4.58M 0.01%
18,460
-110
-0.6% -$28.3K

Similar funds

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.